User profiles for T.M. Gates
 | Thomas GatesIngham Institute for Applied Medical Research Verified email at health.nsw.gov.au Cited by 690 |
[HTML][HTML] The chronicity of HIV infection should drive the research strategy of NeuroHIV treatment studies: a critical review
TM Gates, LA Cysique - CNS drugs, 2016 - Springer
HIV infection has become a chronic illness when successfully treated with combined antiretroviral
therapy (cART). The long-term health prognosis of aging with controlled HIV infection …
therapy (cART). The long-term health prognosis of aging with controlled HIV infection …
Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder
Objective: To investigate whether intensification of combined antiretroviral therapy (cART) with
the CC chemokine receptor type 5 (CCR5) entry inhibitor maraviroc leads to improvement …
the CC chemokine receptor type 5 (CCR5) entry inhibitor maraviroc leads to improvement …
HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research
The Australian HIV-infected (HIV+) population is largely comprised of high-functioning men
who have sex with men (MSM). Like other English-speaking countries, Australia mostly relies …
who have sex with men (MSM). Like other English-speaking countries, Australia mostly relies …
Elevation of cell-associated HIV-1 transcripts in CSF CD4+ T cells, despite effective antiretroviral therapy, is linked to brain injury
Antiretroviral therapy (ART) can attain prolonged undetectable HIV-1 in plasma and
cerebrospinal fluid (CSF), but brain injury remains prevalent in people living with HIV-1 infection (…
cerebrospinal fluid (CSF), but brain injury remains prevalent in people living with HIV-1 infection (…
[HTML][HTML] Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression
… Thomas M Gates has no relevant interests to declare. John McAllister has no relevant …
Cysique LA, Heaton RK, Kamminga J, Lane T, Gates TM, Moore DM, et al. HIV-associated …
Cysique LA, Heaton RK, Kamminga J, Lane T, Gates TM, Moore DM, et al. HIV-associated …
Functional connectivity in virally suppressed patients with HIV-associated neurocognitive disorder: a resting-state analysis
JR Chaganti, A Heinecke, TM Gates… - American Journal …, 2017 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: HIV-associated neurocognitive disorder still occurs despite
virally suppressive combination antiretroviral therapy. In the pre-combination antiretroviral …
virally suppressive combination antiretroviral therapy. In the pre-combination antiretroviral …
Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection
Objective: There is a lack of evidence for the neurobiological underpinning of asymptomatic
neurocognitive impairment (ANI) and mild neurocognitive disorders (MNDs) in virally …
neurocognitive impairment (ANI) and mild neurocognitive disorders (MNDs) in virally …
[HTML][HTML] Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not
Background High antiretroviral therapy (ART) coverage and viral suppression among
people with HIV (PWH) in Australia provide a unique context to study individual cognitive …
people with HIV (PWH) in Australia provide a unique context to study individual cognitive …
Imaging correlates of the blood–brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications
Objective: HIV-associated neurocognitive disorders (HANDs) in the context of suppressive
combination antiretroviral therapy (cART) still occur. We explored the role of blood–brain …
combination antiretroviral therapy (cART) still occur. We explored the role of blood–brain …
How all-type dementia risk factors and modifiable risk interventions may be relevant to the first-generation aging with HIV infection?
Purpose The purpose of this review is to provide an overview of established risk factors for
all-type dementia and results of interventions on dementia modifiable risk factors, all with …
all-type dementia and results of interventions on dementia modifiable risk factors, all with …